Scholarlink

Two combination drug therapies phentermine/topiramate ER and naltrexone ER/bupropion ER have been approved by USFDA for long term management of obesity.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fixed Combination Anti-obesity Medications

  • 章节

  • 发表日期：

    2025年

查看全文
  • Shilpa Chugh Garcha,
  • Sanjay Kalra

摘要

Two combination drug therapies phentermine/topiramate ER and naltrexone ER/bupropion ER have been approved by USFDA for long term management of obesity.